Omega-3 fatty acids in ADHD and related neurodevelopmental disorders (Q34538615)

2 August 2017

1 reference

title

Omega-3 fatty acids in ADHD and related neurodevelopmental disorders (English)

1 reference

neurodevelopmental disorder

2 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Alexandra J Richardson

series ordinal

1

1 reference

2 August 2017

1 April 2006

1 reference

International Review of Psychiatry

2 August 2017

1 reference

2 August 2017

18

1 reference

2 August 2017

155-172

1 reference

2 August 2017

2

1 reference

Sex differences in ADHD: conference summary

2 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Zinc in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Is autism an autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Essential fatty acids and phospholipase A2 in autistic spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Cholesterol, essential fatty acids, and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Polyunsaturated fatty acid status and neurodevelopment: a summary and critical analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Lipid signaling: sleep, synaptic plasticity, and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

A lack of essential fatty acids as a possible cause of hyperactivity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Prevalence and development of psychiatric disorders in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Maternal neuronal antibodies associated with autism and a language disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Essential fatty acids as possible enhancers of the beneficial actions of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Separating attention deficit hyperactivity disorder and learning disabilities in girls: a familial risk analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Response of children with ADHD to methylphenidate: interaction with internalizing symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Attention deficit disorder and conduct disorder: longitudinal evidence for a familial subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Developmental dyslexia: genetic dissection of a complex cognitive trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Essential fatty acids and their role in the treatment of impulsivity disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Maternal dietary docosahexanoic acid content affects the rat pup auditory system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Children with deficits in attention, motor control and perception (DAMP) almost grown up: psychiatric and personality disorders at age 16 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults--the CARDIA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The comorbidity of ADHD in the general population of Swedish school-age children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Influence of long-chain polyunsaturated fatty acid formula feeds on vitamin E status in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The importance of omega-6/omega-3 fatty acid ratio in cell function. The gene transfer of omega-3 fatty acid desaturase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Clinical characteristics and serum essential fatty acid levels in hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The ADHD and sleep conundrum: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Omega-3 fatty acids in the treatment of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The potential role of fatty acids in attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Sex differences in developmental reading disability: new findings from 4 epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

In vivo conversion of linoleic acid to arachidonic acid in human adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

The importance of the ratio of omega-6/omega-3 essential fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Complementary and alternative medicine use in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Cognitive disorders: A question of misattribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Omega-3 fatty acids in boys with behavior, learning, and health problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Visual function, fatty acids and dyslexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Dyslexia in adults is associated with clinical signs of fatty acid deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Could platelet activating factor play a role in developmental dyslexia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Essential fatty acids in visual and brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Nutritional effects on auditory brainstem maturation in healthy term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Plasma fatty acid levels in autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Neuroglial activation and neuroinflammation in the brain of patients with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Maternal antibody-mediated dyslexia? Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Psychiatric comorbidity in children and adolescents with reading disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Membrane phospholipids and cytokine interaction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Omega-6/Omega-3 Ratio and Brain-Related Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

Temperamental correlates of disruptive behavior disorders in young children: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583031

10.1080/09540260600583031

21 January 2018

Identifiers

DOI

1 reference

release_guk4aivribe77asc6xe3l67hvy

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/guk4aivribe77asc6xe3l67hvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16777670

1 reference

PubMed ID

16777670